Novel Cell Therapy Beats Immunotherapy in Melanoma

A novel cell therapy made from tumor infiltrating lymphocytes (TILs) was superior to ipilimumab, and may be a new treatment option for advanced stage melanoma.
Medscape Medical News

source https://www.medscape.com/viewarticle/980543?src=rss